| 11th Mar 2009 2:19 pm |
RNS |
Director/PDMR Shareholding |
| 25th Feb 2009 3:00 pm |
RNS |
Notice of General Meeting |
| 25th Feb 2009 7:00 am |
RNS |
Conditional Investment & Notice of General Meeting |
| 24th Feb 2009 7:00 am |
RNS |
Revenue share agreement with Khandelwal |
| 26th Jan 2009 7:00 am |
RNS |
Strategic Partnership |
| 14th Jan 2009 7:00 am |
RNS |
Positive Phase IIa results for antidepressant |
| 12th Jan 2009 1:23 pm |
RNS |
US patent granted |
| 12th Nov 2008 5:04 pm |
RNS |
Share Option Award |
| 11th Nov 2008 3:02 pm |
RNS |
Grant of patents |
| 31st Oct 2008 7:00 am |
RNS |
Director's Shareholding |
| 10th Oct 2008 12:30 pm |
RNS |
Positive PhaseIIa trial of oral asthma drug |
| 8th Oct 2008 7:00 am |
RNS |
Interim Results |
| 15th Sep 2008 7:00 am |
RNS |
e-Therapeutics partners with KeyGen Biotechnology |
| 4th Sep 2008 4:35 pm |
RNS |
Directorate Change |
| 21st Jul 2008 3:42 pm |
RNS |
Final Results |
| 6th May 2008 7:03 am |
RNS |
Launch of Consultancy Service |
| 4th Apr 2008 2:38 pm |
RNS |
Director/PDMR Shareholding |
| 5th Feb 2008 12:02 pm |
RNS |
Holding(s) in Company |
| 22nd Jan 2008 7:01 am |
RNS |
ETS2101 preclinical progress |
| 10th Dec 2007 11:18 am |
RNS |
Preclinical Update |
| 3rd Dec 2007 4:58 pm |
RNS |
Director/PDMR Shareholding |
| 28th Nov 2007 8:00 am |
RNS |
First day of dealings on AIM |
